Search research articles
Contact Us
Filters
Showing results (51-60 of 163) with videos related to
Page
of 17
Sort By:
Clinical Therapeutics
|
July 10, 2012
Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland
Örjan Åkerborg, Jonas Nilsson, Stephanie Bascle, et al.
The Science of the Total Environment
|
November 30, 2010
Risk of malignancies in relation to terrestrial gamma radiation in a Swedish population cohort
Martin Tondel, Peter Lindgren, Lennart Hellström, et al.
American Journal of Industrial Medicine
|
January 20, 2006
Increased incidence of malignancies in Sweden after the Chernobyl accident--a promoting effect?
Martin Tondel, Peter Lindgren, Peter Hjalmarsson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 2, 2021
Value appropriation in hepatitis C
Peter Lindgren, Sofia Löfvendahl, Gunnar Brådvik, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
January 29, 2010
Factors determining utility measured with the EQ-5D in patients with atrial fibrillation
Jenny Berg, Peter Lindgren, Robby Nieuwlaat, et al.
Clinical Therapeutics
|
August 19, 2007
Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials
Jenny Berg, Peter Lindgren, Julie Spiesser, et al.
Plos One
|
December 1, 2022
Motivation 2 Quit (M2Q): A cluster randomized controlled trial evaluating the effectiveness of Tobacco Cessation on Prescription in Swedish primary healthcare
Anne Leppänen, Peter Lindgren, Carl Johan Sundberg, et al.
JMIR Research Protocols
|
September 18, 2016
A Cluster-Randomized Controlled Trial Evaluating the Effectiveness and Cost-Effectiveness of Tobacco Cessation on Prescription in Swedish Primary Health Care: A Protocol of the Motivation 2 Quit (M2Q) Study
Anne Leppänen, Peter Lindgren, Carl Johan Sundberg, et al.
The International Journal of Health Planning and Management
|
May 16, 2019
Exploring staff experience of economic efficiency requirements in health care: A mixed method study
Sara Korlén, Isis Amer-Wåhlin, Peter Lindgren, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 4, 2023
The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom
Mikel Berdud, Niklas Wallin-Bernhardsson, Bernarda Zamora, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 163) with videos related to
Sort By:
Page
of 17
Clinical Therapeutics
|
July 10, 2012
Cost-effectiveness of dronedarone in atrial fibrillation: results for Canada, Italy, Sweden, and Switzerland
Örjan Åkerborg, Jonas Nilsson, Stephanie Bascle, et al.
The Science of the Total Environment
|
November 30, 2010
Risk of malignancies in relation to terrestrial gamma radiation in a Swedish population cohort
Martin Tondel, Peter Lindgren, Lennart Hellström, et al.
American Journal of Industrial Medicine
|
January 20, 2006
Increased incidence of malignancies in Sweden after the Chernobyl accident--a promoting effect?
Martin Tondel, Peter Lindgren, Peter Hjalmarsson, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 2, 2021
Value appropriation in hepatitis C
Peter Lindgren, Sofia Löfvendahl, Gunnar Brådvik, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
January 29, 2010
Factors determining utility measured with the EQ-5D in patients with atrial fibrillation
Jenny Berg, Peter Lindgren, Robby Nieuwlaat, et al.
Clinical Therapeutics
|
August 19, 2007
Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation: a European model based on the CLARITY and COMMIT trials
Jenny Berg, Peter Lindgren, Julie Spiesser, et al.
Plos One
|
December 1, 2022
Motivation 2 Quit (M2Q): A cluster randomized controlled trial evaluating the effectiveness of Tobacco Cessation on Prescription in Swedish primary healthcare
Anne Leppänen, Peter Lindgren, Carl Johan Sundberg, et al.
JMIR Research Protocols
|
September 18, 2016
A Cluster-Randomized Controlled Trial Evaluating the Effectiveness and Cost-Effectiveness of Tobacco Cessation on Prescription in Swedish Primary Health Care: A Protocol of the Motivation 2 Quit (M2Q) Study
Anne Leppänen, Peter Lindgren, Carl Johan Sundberg, et al.
The International Journal of Health Planning and Management
|
May 16, 2019
Exploring staff experience of economic efficiency requirements in health care: A mixed method study
Sara Korlén, Isis Amer-Wåhlin, Peter Lindgren, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 4, 2023
The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom
Mikel Berdud, Niklas Wallin-Bernhardsson, Bernarda Zamora, et al.
Page
of 17